Murine chronotoxicity to the antiallergic agent, cetirizine

Abstract

Cetirizine is a second-generation histamine H1-receptor antagonist used in the treatment of allergic diseases. The aim of the study was to assess whether cetirizine toxicity estimated by, for example, death, body loss, and leucopenia, is circadian rhythm dependent. A total of 210 male Swiss mice, aged 9 weeks, were synchronized for 3 weeks to 12-hour light (i.e., rest span)/12-hour dark (i.e., activity span) cycles. The drug was administered per os (orally). Each lethal (DL₅₀ =750 mg/kg) and sublethal (DT₅₀ = 55 mg/kg) dose was administered to comparable groups of animals at six different circadian time points (1, 5, 9, 13, 17, and 21 hours after light onset; HALO). The death rate was dosing time dependent (P <0.001). Drug dosing at 5 HALO resulted in maximum mortality (76.75%), whereas dosing at 17 HALO resulted in the lowest mortality rate (16.7%). Cosinor analyses validated a statistically significant circadian rhythm in death rate (P < 0.008). Changes in body weight after cetirizine administration were dosing time dependent (P < 0.01), with the dosing time of least effect (–0.7% loss) at 17 HALO and of greatest effect (–7% loss) at 5 HALO. Cosinor analyses validated a statistically significant circadian rhythm in body loss (P < 0.05). A statistically significant decrease in leukocyte number varied, according to antihistamine dosing time (P < 0.01), with the dosing time of least leucopenia (≈–17%) at 17 HALO and of greatest leucopenia (≈–28%) at 5 HALO. The results show that cetirizine dosing time at the midactivity (dark) span seems to be optimal, since it corresponds to the best tolerance.

Keywords::

• Chronotoxicity
• mice
• cetirizine

Acknowledgments

The authors thank le Ministère de l’Enseignement Supérieur et de Recherche Scientifique de la République Tunisienne. Warmest thanks are also to be addressed to A. Rdissi for proofreading the English text. Authors DD and HBM contributed equally.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.